Briefing documents

High Strength, Fixed Combination and Biosimilar Insulin Products: Minimising the Risk of Medication Error NECS MO summary document for State […]

NICE guidance

The NICE Guidance; Management of medicines in care homes (March 2014) clearly states how commissioners, managers of care homes and other healthcare professionals involved in care homes should work in a standardised format with clear consideration for process and safety.

Prescribing reminder – Subcutaneous methotrexate

Across Darlington, DDES and North Durham CCGs a small number of rheumatology patients who are unsuitable for oral methotrexate are […]

Nalmefene and Psychosocial Support

Nalmefene was recommended for use in “NICE technology appraisal guidance 235: Nalmefene for reducing alcohol consumption in people with alcohol […]

Adrenaline auto-injectors: advice on use from MHRA

In May 2014 the MHRA issued guidance on the use of adrenaline auto-injectors, with the following key messages for patients; […]

Blood glucose testing strip steering group

The blood glucose testing strip steering group met to discuss the progress of the initiative. Practices and patients are engaging […]

Changes in controlled drug legislation for tramadol, lisdexamfetamine, zopiclone and zaleplon

Please see the attached information from the Royal Pharmaceutical Society relating to recent changes in Controlled Drug legislation. CD legislation […]

Prescribing of JEXT – GP

In collaboration with the regional group of Immunologists it was decided that a single adrenaline auto injector device should be […]